sar425899 sanofi dual agonist glp-1 glucagon Transforming obesity: The advancement of multi-receptor drugs: Cell Gut hormone polyagonists for the

Results In total, 204 cases of SSIBs associated with GLP-1RAs, including semaglutide, liraglutide, dulaglutide, exenatide, and albiglutide, were identified in the FAERS database

Results Twenty-eight RCTs were ultimately included for analysis, involving a total of 77,485 participants

Thirteen state Medicaid programs are covering GLP-1 drugs for the treatment of obesity this year, down from 16 last year.

With the increasing use of Glucagon-Like Peptide-1 Receptor (GLP-1R) agonists for diabetes management and weight loss, their implications in perioperative care have gained attention

Refills announces its clinician-led telehealth platform offering GLP-1 weight loss treatments and everyday health solutions

Glucagon increases blood glucose levels, particularly during fasting, and facilitates the mobilization of energy reserves.Synthetic agonists like semaglutide and tirzepatide are stable peptides that specifically activate the receptors of these hormones, amplifying their beneficial effects on glycemic control and weight management